Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your ...

Hinge Health, Inc. engages in the development of technology platform for the treatment of musculoskeletal (MSK) conditions. Its platform addresses a broad spectrum of MSK care, from acute injury to ...

Shares of Humana and other health insurers fell Thursday after the Centers for Medicare & Medicaid Services said it plans to ...

Shares of Humana Inc. rallied 3.94% to $247.34 Monday, on what proved to be an all-around positive trading session for the ...

Revenue Growth: Over the 3M period, Humana showcased positive performance, achieving a revenue ... Analysts typically rate each stock once per quarter. Some analysts will also offer forecasts ...

Despite these developments, Humana's stock performance remained flat over the past week. During the same period, broader markets saw gains, bolstered by strong earnings from major tech companies.

In premarket trading, Humana’s stock rose 6.03%, reflecting investor confidence in the company’s robust performance and strategic outlook. According to InvestingPro analysis, Humana currently appears ...

Still, Humana’s stock was largely flat following the earnings ... few hundred million dollars into strengthening its operating performance, including its stars. Many of those investments ...

their one-week performance, and used relative volume to detect the unusual volume activity. Relative volume compares the daily volume to the three-month average trading volume of the stock ...

We sifted through stock screeners ... several emerging catalysts that could positively affect Humana Inc.’s (NYSE:HUM) future performance, including utilization data from hospitals and managed ...